Search results for "34"

showing 10 items of 1830 documents

Towards a framework for treatment effectiveness in schizophrenia

2014

Georg Juckel,1 Andrea de Bartolomeis,2 Philip Gorwood,3 Sergey Mosolov,4 Luca Pani,5 Alessandro Rossi,6 Julio Sanjuan7 1Department of Psychiatry, LWL-University Hospital, Ruhr-University Bochum, Bochum, Germany; 2Laboratory of Molecular Psychiatry and Unit of Treatment Resistant Psychosis, University School of Medicine of Naples Federico II, Napoli, Italy; 3Groupe Hospitalier Sainte-Anne (CMME), Paris-Descartes University, Paris, France; 4Moscow Research Institute of Psychiatry, Moscow, Russia; 5Institute of Translational Pharmacology, Italian National Research Council, Rome, Italy; 6Università de L’Aquila, L’Aquila, Italy; 7Clinic Hospital, Spanish Mental Hea…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmentAlternative medicineSatisfactionNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseAntipsychoticAssessment scaleExtrapyramidal symptomsmedicineFunctioningCognitive skillAntipsychoticPsychiatryRC346-429Biological PsychiatryDisease burdenOriginal Researchassessment scalesbusiness.industryMental illneMental illnessmedicine.diseasemental illnessAntipsychotic; Assessment scales; Functioning; Mental illness; SatisfactionPsychiatry and Mental HealthMental illnessSchizophreniaNeurology. Diseases of the nervous systemmedicine.symptombusinessAssessment scalesRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: Efficacy following prior methylphenidate trea…

2016

Guanfacine extended release (GXR) and atomoxetine (ATX) are nonstimulant treatments for attention-deficit/hyperactivity disorder (ADHD). As nonstimulant treatments are often used after stimulants in ADHD, GXR was assessed relative to prior stimulant treatment in a randomized controlled trial (RCT), in which ATX was included as a reference arm, and in the open-label phase of a randomized-withdrawal study (RWS). Participants were 6–17 years old with ADHD Rating Scale version IV (ADHD-RS-IV) scores ≥32 and Clinical Global Impressions – Severity scores ≥4. RCT participants received dose-optimized GXR (1–7 mg/day), ATX (10–100 mg/day), or placebo for 10–13 weeks. RWS participants received dose-o…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmenteffectivenessmethylphenidateNeurosciences. Biological psychiatry. NeuropsychiatryPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawInternal medicinemental disordersmedicineAttention deficit hyperactivity disorderADHD0501 psychology and cognitive sciencesPsychiatryRC346-429child and adolescentguanfacineOriginal Researchbusiness.industryMethylphenidate05 social sciencesAtomoxetinetrialmedicine.disease030227 psychiatryGuanfacineinadequate respondersStimulantNeurology. Diseases of the nervous systembusinessGXRatomoxetine050104 developmental & child psychologymedicine.drugRC321-571
researchProduct

Prevalence of eating disorders and eating attacks in narcolepsy

2008

Norbert Dahmen, Julia Becht, Alice Engel, Monika Thommes, Peter TonnPsychiatry Department, University of Mainz, GermanyAbstract: Narcoleptic patients suffer frequently from obesity and type II diabetes. Most patients show a deficit in the energy balance regulating orexinergic system. Nevertheless, it is not known, why narcoleptic patients tend to be obese. We examined 116 narcoleptic patients and 80 controls with the structured interview for anorectic and bulimic eating disorders (SIAB) to test the hypothesis that typical or atypical eating attacks or eating disorders may be more frequent in narcoleptic patients. No difference in the current prevalence of eating disorders bulimia nervosa, b…

medicine.medical_specialtyNeuropsychiatric Disease and TreatmentnarcolepsyNeurosciences. Biological psychiatry. NeuropsychiatryAnorexiaAnorexia nervosaeating attackBinge-eating disordermental disordersMedicinePsychiatryRC346-429Biological PsychiatryOriginal Researchbusiness.industryBulimia nervosadigestive oral and skin physiologymedicine.diseaseObesityPsychiatry and Mental healthEating disordersbulimiaanorexiaeating disorderAnorecticSIABNeurology. Diseases of the nervous systemmedicine.symptombusinessNarcolepsyRC321-571Neuropsychiatric Disease and Treatment
researchProduct

Soccer practice as an add-on treatment in the management of individuals with a diagnosis of schizophrenia

2013

Giuseppe Battaglia,1,3 Marianna Alesi,2 Michele Inguglia,4 Michele Roccella,2 Giovanni Caramazza,3 Marianna Bellafiore,1,3 Antonio Palma1,3 1Department of Law, Social and Sport Science, University of Palermo, Palermo, Italy; 2Department of Psychology, University of Palermo, Palermo Italy; 3Regional Sports School of CONI Sicilia, Sicily, Italy; 4Local Health of Palermo, Palermo, Italy Abstract: Physical activity is an important aspect of good health for everyone; it is even more important for psychiatric patients who usually live an unhealthy lifestyle. In recent years, there has been growing focus on the use of soccer as a vehicle to improve the health of subjects with severe mental illness…

medicine.medical_specialtyNeuropsychiatric Disease and Treatmentpsychotic subjectsmedicine.medical_treatmentNeurosciences. Biological psychiatry. NeuropsychiatrySettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'EducazioneMedicineRC346-429schizophrenia mental illness psychotic subjects sport exercise soccerAntipsychoticBiological PsychiatryOriginal ResearchSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' Sportiveexercisebusiness.industryAnthropometryMental illnessmedicine.diseasemental illnesssoccerSettore MED/39 - Neuropsichiatria InfantileschizophreniaPsychiatry and Mental healthAdd on treatmentSprintPhysical therapyNeurology. Diseases of the nervous systemmedicine.symptomsportbusinesshuman activitiesBody mass indexWeight gainRC321-571Diagnosis of schizophreniaNeuropsychiatric Disease and Treatment
researchProduct

Neuropsychology and anorexia nervosa. Cognitive and radiological findings

2012

Introduction: Research into neuropsychological impairments present in the patients suffering from anorexia nervosa (AN) has advanced considerably, in the past decades. It now provides neuropsychologists with a wide field of knowledge of the changes found in the cerebral and cognitive capabilities of these patients, as well as their reversible or static features, thereby yielding a characteristic profile of neuropsychological impairment in AN. Development: We present a review updated to December 2010 of the results delivered by studies of both morphological and cognitive changes, providing us with an updated theoretical and practical framework for conducting future research. Conclusions: The…

medicine.medical_specialtyNeuropsychologyPosterior parietal cortexCognitionDiseaseWide fieldlcsh:RC346-429Anorexia nervosa (differential diagnoses)Radiological weaponCognitive ChangesmedicinePsychologyPsychiatrylcsh:Neurology. Diseases of the nervous systemNeurología (English Edition)
researchProduct

Engraftment kinetics of human CD34+ cells from cord blood and mobilized peripheral blood co-transplanted into NOD/SCID mice

2004

We have reported short periods of post transplant neutropenia in human patients co-transplanted with cord blood (CB) and low numbers of haploidentical mobilized peripheral blood (MPB) CD34+ cells. To investigate the effect that the proportion of MPB to CB cells may have on engraftment kinetics, we have co-transplanted fixed numbers of human CB CD34+ cells mixed with different numbers of MPB CD34+ cells into NOD/SCID mice. We periodically quantified the proportion of human cells and the relative contribution of MPB and CB cells to the human engraftment on marrow aspirates. At the lowest MPB/CB ratios (5 : 1, 10 : 1), the contribution of CB cells predominated at all time points analyzed, and …

medicine.medical_specialtyNeutropeniaTransplantation HeterologousCD34Antigens CD34Mice SCIDCord Blood Stem Cell TransplantationNeutropeniaBlood cellMiceAntigenMice Inbred NODInternal medicinemedicineAnimalsHumansPeripheral Blood Stem Cell TransplantationTransplantationHematologybusiness.industryGraft SurvivalHematologymedicine.diseaseMolecular biologyTransplantationKineticsmedicine.anatomical_structureCord bloodModels AnimalImmunologyCord Blood Stem Cell TransplantationbusinessBone Marrow Transplantation
researchProduct

Effects of alfa-hydroxy-isocaproic acid on body composition, DOMS and performance in athletes

2010

Abstract Background Alfa-Hydroxy-isocaproic acid (HICA) is an end product of leucine metabolism in human tissues such as muscle and connective tissue. According to the clinical and experimental studies, HICA can be considered as an anti-catabolic substance. The present study investigated the effects of HICA supplementation on body composition, delayed onset of muscle soreness (DOMS) and physical performance of athletes during a training period. Methods Fifteen healthy male soccer players (age 22.1+/-3.9 yr) volunteered for the 4-week double-blind study during an intensive training period. The subjects in the group HICA (n = 8) received 583 mg of sodium salt of HICA (corresponding 500 mg of …

medicine.medical_specialtyNutrition and DieteticsSports medicinebiologyStrength trainingAthletesbusiness.industrylcsh:TX341-641Clinical nutritionPlaceboBody weightbiology.organism_classificationEndocrinologyInternal medicineResearch articleLean body massPhysical therapymedicineComposition (visual arts)lcsh:Sports medicinelcsh:RC1200-1245businesslcsh:Nutrition. Foods and food supplyFood ScienceJournal of the International Society of Sports Nutrition
researchProduct

Moderate energy restriction with high protein diet results in healthier outcome in women

2010

Abstract Background The present study compares two different weight reduction regimens both with a moderately high protein intake on body composition, serum hormone concentration and strength performance in non-competitive female athletes. Methods Fifteen normal weighted women involved in recreational resistance training and aerobic training were recruited for the study (age 28.5 ± 6.3 yr, height 167.0 ± 7.0 cm, body mass 66.3 ± 4.2 kg, body mass index 23.8 ± 1.8, mean ± SD). They were randomized into two groups. The 1 KG group (n = 8; energy deficit 1100 kcal/day) was supervised to reduce body weight by 1 kg per week and the 0.5 KG group (n = 7; energy deficit 550 kcal/day) by 0.5 kg per w…

medicine.medical_specialtyNutrition and Dieteticsbusiness.industrylcsh:TX341-641High-protein dietSquatmedicine.disease_causeBench pressJumpingEndocrinologyWeight lossInternal medicineResearch articlemedicineLean body massAerobic exerciselcsh:Sports medicinemedicine.symptomlcsh:RC1200-1245businesslcsh:Nutrition. Foods and food supplyBody mass indexFood ScienceJournal of the International Society of Sports Nutrition
researchProduct

Gait Disorders Questionnaire–Promising Tool for Virtual Reality Designing in Patients With Parkinson's Disease

2019

Background: Gait disorders (GD) are frequent and disabling symptoms in patients with Parkinson's disease, mostly because they significantly limit mobility and often lead to fear of falls or actual falls. Nowadays, rehabilitation is considered to be the most effective nonpharmacological approach to reduce risk of falls. Using paradigms in virtual reality (VR) is a promising tool in neurorehabilitation because of the potential improvement in motor learning and improvement in daily functioning by replicating everyday real-life scenarios. Objective: To identify the most prevalent everyday situations which impair gait in PD that could be simulated in virtual reality (VR) environment. Methods: A …

medicine.medical_specialtyParkinson's diseaseParkinson's diseasemedicine.medical_treatmentMokken scaleDiseaseVirtual realitygaitlcsh:RC346-429freezing of gait03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicine030212 general & internal medicinelcsh:Neurology. Diseases of the nervous systemNeurorehabilitationOriginal ResearchneurorehabilitationRehabilitationbusiness.industrymedicine.diseaseGaitNeurologyvirtual realityNeurology (clinical)Motor learningbusiness030217 neurology & neurosurgeryFrontiers in Neurology
researchProduct

Mercaptopurine Treatment in an Adult Man with Orbital and Intracranial Rosai-Dorfman Disease.

2016

Background. Rosai-Dorfmann disease (RDD) is a rare, idiopathic non-Langerhans cell histiocytosis, affecting children and young adults, that commonly presents as painless, massive cervical lymphadenopathy with fever, weight loss, and polyclonal hypergammaglobulinemia. Cervical lymphadenopathy and extranodal involvement are the main presentations. On the contrary, ophthalmic involvement and localisation in the central nervous system are rare.Case Report. An old man was admitted to our hospital for first seizure. Brain imaging studies revealed on the left an extra-axial thickening of the dura mater with enhancement and perilesional oedema, infiltrating the sphenoorbital fissure and an isointen…

medicine.medical_specialtyPathologyDura materRosai-Dorfmann disease mercaptopurine treatmentCase Reportlcsh:RC346-42903 medical and health sciences0302 clinical medicineCervical lymphadenopathymedicineExtranodal Involvementlcsh:Neurology. Diseases of the nervous systemRosai–Dorfman diseasebusiness.industrymedicine.diseaseDebulkingMercaptopurineHistiocytosismedicine.anatomical_structure030220 oncology & carcinogenesisOptic nerveRadiologymedicine.symptomGeneral Agricultural and Biological Sciencesbusiness030217 neurology & neurosurgerymedicine.drug
researchProduct